Axovia Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| First-in-Human, Dose Escalation Trial of AXV-101 in BBS1-Related Retinal Degeneration (NCT07269665) | Axovia Therapeutics | 2026-06-26 |
Track Axovia Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.